West Pharmaceutical rises after lifting annual profit forecast

West Pharmaceutical Services

23/10/2025 12:19

** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 7.2% to $297 premarket

** WST lifts full-year adjusted EPS outlook to $7.06–$7.11 from $6.65–$6.85

** Co raises sales forecast to $3.06–$3.07 bln from $3.04–$3.06 bln

** Co reports Q3 adjusted EPS of $1.96 vs analysts' average estimate of $1.68, as per data compiled by LSEG

** WST's quarterly revenue of $804.6 mln beats Wall Street expectations of $787.9 mln

** Up to last close, stock down ~15% YTD

 (Compiled by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))